Please login to the form below

Not currently logged in
Email:
Password:

Actavis looks to PepsiCo for CFO

Maria Teresa Hilado will help guide company through Allergan aquisition
Maria Teresa Hilado actavis

Maria Teresa Hilado has left her role at PepsiCo to join pharma company Actavis as chief financial officer.

Hilado was most recently senior VP, finance and treasurer at PepsiCo, which markets consumer products such as Pepsi Cola, Lay's potato chips and Tropicana fruit juice.

She now moves to a role in healthcare at Actavis, which is in the middle of increasing its business with the purchase of Allergan, the makers of Botox and several eyecare products.

Hilado's experience in completing large deals was one of the main appeals for Actavis, according to CEO and president Brent Saunders.

"She will bring extensive expertise in global finance, mergers and acquisitions and business development, and is widely recognised for her exceptional leadership skills,” said Saunders.

Hilado joined PepsiCo in 2009 having spent a year at Schering-Plough as VP and treasurer.

Prior to this role she spent more than 17 years at car manufacturers General Motors, most recently as assistant treasurer.

She also serves on the board of directors of adhesive manufacturer H.B. Fuller and previously served on the board of directors of Bausch & Lomb, a healthcare company that was taken over by Valeant Pharmaceuticals in 2013.

18th November 2014

From: Sales

Share

Tags

COVID-19 Updates and Daily News

Featured jobs

PMHub

Add my company
AMICULUM Limited

AMICULUM® is an independent global healthcare communications, consulting and learning business with a global team of >220 healthcare communications professionals,...

Latest intelligence

What challenges still face clinical trial recruitment and retention?
Discover the reasons for the current clinical trial recruitment challenges facing pharma and the life sciences industry, and how the search for solutions to the problem continues...
“Fake News” and Credibility in Medical Publishing
Natalie Yeadon from Impetus Digital shares her thoughts on fighting fake news in Pharma and healthcare....
Delivering true value: what does it mean for KAM in cancer care?
Lisa Alderson, Business Development Director at Wilmington Healthcare, explores the challenges that pharma’s KAM teams face in engaging with the NHS and how they must evolve...

Infographics